PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase

Por Alonso-Dominguez, Juan M., Casado, Luis Felipe, Anguita, Eduardo, Gomez-Casares, Maria Teresa, Buño, Ismael, Ferrer-Marín, Francisca, Arenas, Alicia, Del Orbe, Rafael, Ayala, Rosa, Llamas, Pilar, Salgado, Rocio N., Osorio, Santiago, Sanchez-Godoy, Pedro, Burgaleta, Carmen, Mahíllo-Fernández, Ignacio, Garcia-Gutierrez, Valentin, Steegmann, Juan Luis, Martinez-Lopez, Joaquín
Publicado no PLoS One (2017)

Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy

Por Balbás-Martínez, Cristina, Sagrera, Ana, Carrillo-de-Santa-Pau, Enrique, Earl, Julie, Márquez, Mirari, Vazquez, Miguel, Lapi, Eleonora, Castro-Giner, Francesc, Beltran, Sergi, Bayés, Mònica, Carrato, Alfredo, Cigudosa, Juan C., Domínguez, Orlando, Gut, Marta, Herranz, Jesús, Juanpere, Núria, Kogevinas, Manolis, Langa, Xavier, López-Knowles, Elena, Lorente, José A., Lloreta, Josep, Pisano, David G., Richart, Laia, Rico, Daniel, Salgado, Rocío N., Tardón, Adonina, Chanock, Stephen, Heath, Simon, Valencia, Alfonso, Losada, Ana, Gut, Ivo, Malats, Núria, Real, Francisco X.
Publicado em 2013